HPV-based Screening Among Women 23-29 Years of Age
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age23-29
SponsorKarolinska Institutet
About this trial
The aim of the trial is to determine whether organized screening with primary HPV analysis provide higher cancer protection in the age group 23-29 years compared to primary cytology.
Eligibility criteria
Qualifiers
Women ages 23-29 invited to screening.
Disqualifiers
Women who do not show up for screening or do not consent.
Trial design
Treatments tested in this trial
- HPV testing
Treatment groups
180,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov